Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Korea Health Reporter.
Press releases published on April 30, 2025

WellSpan Surgery and Rehabilitation Hospital reaccredited with top Magnet designation
York, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- WellSpan Surgery and Rehabilitation Hospital in York has been reaccredited as a Magnet hospital, the highest honor for nursing, awarded by the American Nurses Credentialing Center (ANCC). As part of the …

Spark Biomedical Secures $15M Series A To Advance Drug-Free Wearable Neurostimulation Therapies
Dallas, TX, April 30, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a leading health tech innovator in wearable neurostimulation technology, has closed its $15M Series A round—led by WAVE Ventures and supported by Pathway to Cures—to accelerate the …

X-Chem Expands Strategic Collaboration With Orion Pharma to Accelerate Orion’s Early Drug Discovery From Hit to Candidate
WALTHAM, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- X-Chem, a global leader in DNA-encoded library (DEL) technology and data-driven drug discovery, has announced an expanded collaboration with Orion Pharma. The agreement builds on an existing relationship …

ScribeAmerica to Showcase Provider Enablement Solutions at UCA’s 2025 Urgent Care Convention
FORT LAUDERDALE, FLORIDA, April 30, 2025 (GLOBE NEWSWIRE) -- ScribeAmerica is proud to announce its participation in the 2025 Urgent Care Convention, taking place May 2-6 in Dallas, TX. The company will exhibit in the Solutions. Expo at booth #1019, where …

BioSyent to Present at 2025 Bloom Burton & Co. Healthcare Investor Conference
MISSISSAUGA, Ontario, April 30, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2025 Bloom Burton …

HLTH 2025 Launches Groundbreaking New Experiences in AI, Pharma, and Diagnostics – While Returning Classics Get a Fresh Twist
LAS VEGAS, April 30, 2025 (GLOBE NEWSWIRE) -- HLTH Inc., the catalyst for global healthcare innovation, returns to Las Vegas on October 19–22, 2025, with a bold new agenda designed to redefine the future of healthcare. Led by new, immersive marketplaces …

Best Male Enhancement Pills – Top Natural Male Enhancement Supplements & Gummies: Erectin Under Review By Leading Edge Health
Limassol, Cyprus, April 30, 2025 (GLOBE NEWSWIRE) -- Every man wants to perform like a stud in the bedroom and beyond. We’d like to wield powerful erections, climax with massive force, last all night long, and leave our partners begging for more. The best …

INVO Fertility Announces 2024 Financial Results with 116% Annual Revenue Growth and Further Improvements in Adjusted EBITDA
SARASOTA, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and …

Helius Medical Technologies Announces Reverse Stock Split
NEWTOWN, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced …

Senti Bio to Present at the Citizens JMP Life Sciences Conference
Live video webcast presentation on Thursday, May 8th at 1:00 PM ET Presentation will highlight the recently announced positive preliminary clinical results of lead program, SENTI-202, in the treatment of patients with Relapsed/Refractory AML SOUTH SAN …

PathAI to Present at Digestive Disease Week
BOSTON, April 30, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology solutions, today announced it will present research from the outputs of IBD ExploreTM and AIM-HI UCTM at Digestive Disease Week (DDW) from May 3-6, 2025, in San …

Medicenna Presents Promising Preclinical Data from its First-in-Class Tumor Targeted and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the Annual 2025 AACR Meeting
MDNA113 is a novel IL-13Rα2 tumor-targeted and “masked” anti-PD-1-IL-2 Superkine (anti-PD1-IL-2SK), engineered to precisely deliver clinically validated anti-PD1 and IL-2SK to the tumor microenvironment (TME) IL-13Rα2 is overexpressed by some of the most “ …

PharmAla Issues Q2 Financial Statements
TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA …

Elligint Health Partners with CareCo to Transform Care Coordination and Utilization Management with Advanced AI Workflow Tools and Integrated AI-Powered VoIP System
KINGSTON, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Elligint Health, parent company of VirtualHealth, is excited to announce a strategic partnership with CareCo to deliver next-generation healthcare solutions. This groundbreaking collaboration will integrate …

Magnesium Breakthrough Under Review: Does BiOptimizers Magnesium Breakthrough Work? Best Magnesium Supplements!
Albany, New York, April 30, 2025 (GLOBE NEWSWIRE) -- Stress is responsible for a lot of illnesses, and contrary to what people believe, it does not enter the body out of thin air. A person becomes stressed when there is a deficiency of Magnesium in the …

Cell Counting Market to Hit US$16.14 Billion by 2029 with 7.7% CAGR | MarketsandMarkets™.
Delray Beach, FL, April 30, 2025 (GLOBE NEWSWIRE) -- The global cell counting market, valued at US$10.82 billion in 2023, is forecasted to grow at a robust CAGR of 7.7%, reaching US$11.12 billion in 2024 and an impressive US$16.14 billion by 2029. …

Lantheus Announces Alzheimer’s Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies
BEDFORD, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, …

Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis
– Pearce joins NHL Hall-of-Famer, Henrik Lundqvist, to educate patients and caregivers about the importance of accurate and early diagnosis of recurrent pericarditis, a chronic autoinflammatory disease of the heart that is often underdiagnosed or …

Better Choice Company Completes Name Change to SRx Health Solutions Inc. and Begins Trading Under the Ticker Symbol ‘SRXH’ Today, Wednesday, April 30, 2025
TAMPA, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (NYSE American: SRXH) (“Better Choice” or the “Company”), a leading global health and wellness company, today announced completing its name change to SRx …

Rakovina Therapeutics Inc. Announces 2024 Financial Results and Provides Corporate Update
VANCOUVER, British Columbia, April 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery announced …